shape poster
poster

Presented at: ASCO 2019

A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma

Register here for download

Relevant for

FixVUE, InSituPlex

Presented at SITC 2019.

Authors

Schwarze JK., Awada G., Cras L., Forsyth R., Dufait I., Van Reit I. and Neyns B.

Want to meet with us? Check out our upcoming events.

Want to meet with us? Check out our upcoming events.